1. O'Malley G, Moran C, Draman MS, King T, Smith D, Thompson CJ, et al. Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state. Ann Clin Biochem. 2008; 45:440–443.
2. Burns JD, Kosa SC, Wijdicks EF. Central pontine myelinolysis in a patient with hyperosmolar hyperglycemia and consistently normal serum sodium. Neurocrit Care. 2009; 11:251–254.
Article
3. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959; 81:154–172.
4. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004; 75 Suppl 3:iii22–iii28.
Article
5. Hirosawa T, Shimizu T. Osmotic demyelination syndrome due to hyperosmolar hyperglycemia. Cleve Clin J Med. 2018; 85:511–513.
Article
6. Saini M, Mamauag MJ, Singh R. Central pontine myelinolysis: a rare presentation secondary to hyperglycaemia. Singapore Med J. 2015; 56:e71–e73.
Article
7. Chang YM. Central pontine myelinolysis associated with diabetic hyperglycemia. JSM Clin Case Rep. 2014; 2:1059.
8. Rodríguez-Velver KV, Soto-Garcia AJ, Zapata-Rivera MA, Montes-Villarreal J, Villarreal-Pérez JZ, Rodríguez-Gutiérrez R. Osmotic demyelination syndrome as the initial manifestation of a hyperosmolar hyperglycemic state. Case Rep Neurol Med. 2014; 2014:652523.
Article
9. Linyu N, Das BR, Mossang K, Singh SR, Prasad L, Naorem S. Osmotic demyelination syndrome occurs early in the course of hyperosmolar Hyperglycemic state. IOSR-JDMS. 2017; 16:25–22.
10. Osborn AG, Salzman KL, Jhaveri MD, Barkovich AJ. Diagnostic imaging: brain. 3rd ed. Philadelphia: Elsevier;2015.